AI Disrupting Medical Publication and How to Handle It

Monday, March 10, 2025

2:05 PM – 2:13 PM ET

Speaker(s)

Harlan M. Krumholz, MD

Director, Center for Outcomes Research and Evaluation
Yale-New Haven Hospital, Connecticut, United States

Disclosure(s): Concept Medical, CSL Behring, Cytosorbents, Daiichi Sankyo, Element Science, Faraday, Filterlex Medical, Humacyte, Idorsia Pharmaceuticals, Janssen, Mediasphere, Medtelligence: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); ENSIGHT-AI: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Eyedentify: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Johnson and Johnson: Grant/Research Support (Ongoing)

Disclosure(s):

Harlan M. Krumholz, MD: Concept Medical, CSL Behring, Cytosorbents, Daiichi Sankyo, Element Science, Faraday, Filterlex Medical, Humacyte, Idorsia Pharmaceuticals, Janssen, Mediasphere, Medtelligence: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); ENSIGHT-AI: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Eyedentify: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Johnson and Johnson: Grant/Research Support (Ongoing)